Improving the quality of life in patients with idiopathic Parkinson's disease through individualized holistic care within the framework of the Cologne PD Network

Not Applicable

• Conditions: G20; Parkinson disease

• Registration Number: DRKS00003452
• Lead Sponsor: niklinik KölnKlinik für Neurologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-12-23
• Study Completion: 2015-07-22
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

• male and female patients with clinical diagnosis of idiopathic Parkinson syndrome (IPS)
• Patients aged between 25 and 85 years
• patients must be able to consent and sign a consent form
• patients must have good knowledge of German

Exclusion Criteria

• Patients who suffer from a cognitive-impairing disease (eg. vascular events, tumors, etc.)
• Patients with depression (BDI> 30 points) and/or dementia (PANDA <14 points)
• Expected incompliance of participation in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Survey of quality of life at baseline and after six months by a questionnaire (Parkinson's Disease Quality of Life Questionnaire (PDQ-39))

Secondary Outcome Measures

Name	Time	Method
Survey of the following parameters at baseline and after six months:<br>Disease stage: Hoehn & Yahr scale (assessment by physician)<br>Disease severity: United Parkinson's Disease Rating Scale (UPDRS) Part III (video recording, blinded assessment by physician)<br>Non-motor symptoms: non-motor symptoms scale (NMS) (Questionnaire)<br>Depression: Beck's Depression Inventory (BDI) (Questionnaire)<br>cognitive deficits: Psychometric Neuroscience Parkinson Dementia Assessment (PANDA) (Questionnaire)<br>Phases of over- or undermobility: movement diary<br>Medication: Medication Diary